Sandra J Casak Selected Research

Sandra J Casak Research Topics

3	Asthenia 01/2022 - 01/2021
3	Fatigue 01/2022 - 01/2021
3	Diarrhea 01/2022 - 01/2021
2	Nausea 01/2022 - 01/2021
2	Retinoblastoma (Glioblastoma, Retinal) 05/2005 - 03/2004
1	Ascites 01/2022
1	Cough 01/2022
1	Cholangiocarcinoma 01/2022
1	Disease Progression 01/2022
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Vomiting 01/2022
1	Hemorrhage 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Proteinuria 01/2021
1	Varicose Veins (Varicose Vein) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Microsatellite Instability 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Stomach Neoplasms (Stomach Cancer) 08/2015
1	Adenocarcinoma 08/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2011
1	Neoplasms (Cancer) 02/2002

2	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2018
1	ivosidenibIBA 01/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	atezolizumabIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Biosimilar PharmaceuticalsIBA 01/2018
1	RamucirumabIBA 08/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2011
1	Rituximab (Mabthera)FDA Link 01/2011
1	fludarabineIBA 01/2011
1	Pharmaceutical PreparationsIBA 03/2004
1	Topotecan (Hycamtin)FDA LinkGeneric 03/2004

4	Therapeutics 01/2022 - 02/2002
1	Drug Therapy (Chemotherapy) 01/2022